TWM478489U - Antrodia cinnamomea powder capsule structure for suppressing hepatitis B virus - Google Patents

Description

A capsule structure of Antrodia camphorata for inhibiting hepatitis B virus

This creation relates to the technical field of a capsule structure that can embed powder.

Antrodia camphorata, also known as Antrodia camphorata or Burdock mushroom, belongs to the fungi community (Fungi), Basidiomycota, Basidiomycotina, Homobasidiomycetes, and taxonomy. Aphyllophorales, Polyporaceae, Antrodia. Antrodia camphorata grows in the deep mountains of 450~2000 meters above sea level, also known as burdock mushroom, red peony, oyster mushroom, and oyster mushroom. It grows only on the inner wall of the decaying heartwood of Taiwan's unique burdock trunk. Niobium lucidum is known to have a variety of active ingredients, which makes the Antrodia camphorata have the reputation of "protecting the liver, enhancing immunity, inhibiting hepatitis B virus activity, etc." and has the reputation of "ruby in the forest".

The body of Ox sylvestris is perennial, sessile and cork-to-wood. It has a strong aroma of eucalyptus and has a variety of shapes. It has a plate shape, a bell shape, a horseshoe shape or a tower shape. It is close to the surface of the wood and has a pore shape on the surface of the mushroom. It is bright red at the beginning of life, and becomes milky white, reddish brown, light brown or yellowish brown as the growth progresses. The periphery is often radial and spreads to the periphery, showing a semicircular or irregular shape.

Phytochemical studies have shown that the fruit body of A. angustifolia contains polysaccharides (30-50%), three 萜 Classes (30%), steroids, superoxide dismutase and amino acids. In Taiwan's folk medicine therapy, the body of A. sylvestris is considered to have certain medical effects. The fruiting body is finely ground into a dry powder or taken orally in a boiled way. It is a food-borne mushroom with a curative effect and has anti-hepatitis B. Virus and treatment of liver disease and other activities.

Hepatitis B is a disease caused by hepatitis B virus infection and has a high prevalence rate in Taiwan and the southeastern part of the mainland. It is usually transmitted through blood or body fluids (such as semen, tissue fluid). Normal skin has the function of protecting foreign bacteria. Therefore, even if it comes into contact with the patient's body fluid, as long as the contact's skin has no wound, the chance of being infected is Very small, and the chance of being infected by saliva is lower than that of blood or body fluids, so it is not necessary to worry about eating with patients with hepatitis B. However, if the mucous membrane is partially exposed to the body fluids of patients with hepatitis B (such as the eyes, genital mucosa, oral mucosa), the chance of being infected is relatively large. After infection with hepatitis B, the virus mainly causes inflammation of the liver, so it is possible Causes acute hepatitis, causing fatigue, jaundice, loss of appetite and so on. In addition, a group of patients will get along with the virus for a long time, becoming a chronic hepatitis patient or a hepatitis B carrier.

This group of patients with chronic hepatitis B carriers is often asymptomatic, but if the number of viruses increases rapidly, this group of patients may also become acute hepatitis attacks. After many episodes of acute hepatitis, some patients will have cirrhosis, and some people will also develop liver cancer. A small number of patients with extrarahepatic manifestations are generally believed to be caused by the virus's immune response, causing the immune complex in the circulation to cause arthritis, rash, vasculitis, condensed globulinemia, or kidney. Silk glomerulonephritis and aplastic anemia.

According to the statistics of the Hepatitis B Medical Policy Association, there are about 3 million hepatitis B in Taiwan. With the original, it is equivalent to one in five people in an adult. The liver-based association believes that one out of every five to six people born before the Republic of China seventy-three years ago has a surface antigen of hepatitis B virus. Taiwan has been fully vaccinated against hepatitis B since July 1, 1984. Although it may sever the continued spread of hepatitis B, nearly four million people in Taiwan have become the carriers of hepatitis B.

Most patients with acute hepatitis B can heal themselves, so most patients with acute hepatitis B without complications can take supportive care. In some patients, intravenous infusion is required for dehydration due to poor appetite or severe vomiting.

Hepatitis B is highly correlated with liver cirrhosis and liver cancer, and the probability of hepatitis B with the liver is many times higher than that of the average person. According to the statistics of the top ten causes of death in Taiwan, since the Republic of China, cancer has leapt to the top in the past seventy-one years. Among them, liver cancer ranks first in male cancer mortality, and it also ranks second in female cancer mortality. Symptoms, if the liver cancer is found late, it is difficult to treat, but if it is discovered early, the treatment effect is good. The current method of prevention and treatment begins with "early diagnosis, early treatment" and taking health food prevention.

At present, many experiments have revealed that the body of A. angustifolia has the effect of inhibiting hepatitis B virus, and its components are also analyzed. Therefore, providing a better treatment or prevention of hepatitis B in these patients is an urgent problem to be solved.

Therefore, the creators of this case, in view of the above-mentioned lack of derivative, are thinking and improving and innovating, in addition to the development of a burdock powder, the active ingredient of which inhibits hepatitis B virus; in addition, with the capsule structure of the creation, it is easy for the user to use. Ingest enough of the Antrodia camphorata powder to inhibit the hepatitis B virus. Therefore, this article "a structure of a capsule of Astragalus membranaceus for inhibiting hepatitis B virus" is proposed.

The purpose of the present invention is to provide a capsule structure of Antrodia camphorata for inhibiting hepatitis B virus.

A second object of the present invention is to provide a capsule structure in which the active ingredient of the Antrodia camphorata powder can exert its effect of inhibiting hepatitis B virus in a user.

The invention relates to a structure of an Antrodia camphorata powder capsule for inhibiting hepatitis B virus, comprising: a capsule shell, a protective layer, and a core; the core layer is covered by the protective layer, and the protective layer is further Covered by a capsule.

The structure of the Antrodia camphorata powder capsule provided by the present invention can be preserved for a long time in addition to the contained Antrodia camphorata powder (and its active ingredient); in addition, the core of the Antrodia camphorata powder (and its active ingredient) can also inhibit B Hepatitis virus. The capsule structure provided by this creation can be easily taken by the user, so that it can be used in combination with other treatments in addition to daily health care.

1‧‧‧Capsule structure

11‧‧‧ capsule

12‧‧‧Protective layer

13‧‧‧ core

Figure 1 is a cross-sectional view showing the structure of an Antrodia camphorata powder capsule for inhibiting hepatitis B virus.

The present invention provides a structure of an Antrodia camphorata powder capsule for inhibiting hepatitis B virus, which is described in detail in accordance with the present creation, and is described in the first figure.

One of the creations of the Antrodia camphorata powder capsule for inhibiting hepatitis B virus The structure 1 includes, from the outside to the inside, a capsule 11, a protective layer 12, and a core 13; the core 13 is covered by the protective layer 12, except that it can be used to block the external environment and the core 13 In addition to the oxidation, it can also be used to protect the active constituents of the Antrodia camphorata in the core 13 from diseases such as gastric acid. In addition, the protective layer 12 is further covered by a capsule 11 to protect the core 13 and the protective layer 12 from physical factors such as heavy pressure, spikes, and the like.

The components used in the capsule 11 include, but are not limited to, gelatin (Gelatin), Methyl cellulose, Hydroxymethyl propyl cellulose, Hydroxypropyl cellulose ( Hydroxymethyl propyl cellulose), polyvinyl alcohol, polyvinyl pyrrolidone, Cellulose acetate phthalate, Hydroxypropyl methyl phthalate or Other materials suitable for use in the present invention; wherein the gelatin may comprise animal gelatin (made from animal sources such as fish skin, pig skin, etc.) and vegetable gelatin (eg, hydroxypropyl methylcellulose (HPMC)).

The protective layer 12 may include, but is not limited to, an excipient, a disintegrant, an enteric coating, a binder, a diluent, a coating agent, a swelling agent, a lubricant, a flavoring agent, a sweetener, a solubilizing agent. Or any combination thereof.

Wherein, the excipient may be a sugar, including lactose, sucrose, mannitol, sorbitol; the cellulose preparation is, for example, corn starch, wheat starch, rice starch, potato starch, gelatin, tragacanth, etc. or other Materials suitable for this creation; they can be used to increase the mouthfeel, support the overall structure, and protect the core 13.

The core 13 contains an antrodia arsenic powder (active substance) which can be used to inhibit the hepatitis B virus. The Antrodia camphorata powder can be made from the fruit body of Antrodia camphorata.

The above-mentioned capsule structure 1 may also be suitably added with one or more kinds of preservatives, colorants, flavors and flavors or other additives suitable for the present invention which are commonly used in the field, so as to shape, preserve and color. Add flavor.

The above powder capsule structure can be prepared by taking it in a capsule for oral administration, or by taking it directly or by other forms suitable for the present invention.

The detailed description above is a detailed description of one of the possible implementations of the present invention, but the embodiment is not intended to limit the scope of the patents of the present invention, and equivalent implementations or modifications that are not departing from the spirit of the present invention should be included in The patent scope of this case.

In summary, the technical features disclosed in this case have fully met the statutory patent requirements for novelty, advancement and industrial applicability. If you apply in accordance with the law, you are requested to approve the new patent application for your invention. Will.

1‧‧‧Capsule structure

11‧‧‧ capsule

12‧‧‧Protective layer

13‧‧‧ core

Claims (5)

A structure of an Antrodia camphorata powder capsule for inhibiting hepatitis B virus, comprising: a capsule shell, a protective layer, and a core from the outside to the inside; the core layer is covered by the protective layer, and the protective layer is further Covered by a capsule. The capsule structure according to claim 1, wherein the composition of the capsule comprises gelatin, methylcellulose, hydroxypropylmethylcellulose, hydroxypropylcellulose, polyvinyl alcohol, polyvinylpyrrolidone, Cellulose acetate phthalate, hydroxypropyl cellulose phthalate. The capsule structure according to claim 1, wherein the protective layer component comprises an excipient, a disintegrating agent, an enteric coating, a binder, a diluent, a coating agent, a swelling agent, a lubricant, and a seasoning. Agent, sweetener, solubilizer. The capsule structure of claim 3, wherein the component of the excipient comprises lactose, sucrose, mannitol, sorbitol, corn starch, wheat starch, rice starch, potato starch, gelatin, tragacanth. The capsule structure of claim 1, wherein the core comprises anthraquinone powder prepared from a body of A. nigra.